There are a variety of resources available for guidance on navigating contracts with pharmacy benefit managers, but you have to be cautious about whos supplying the information.
Increasingly, both private and public sector groups are beginning to take a careful look at the practices of pharmacy benefits managers as employers and taxpayers become curious about massive PBM profits and unclear contracts.
As state legislatures grappling with budget shortfalls search high and low for every possible angle to cut costs, big insurance companies and pharmacy benefit managers have managed to convince a handful of states to transition their Medicaid programs into a Managed Care model.
As Plavix loses its patent protection and Lipitor faces competition from multi-source generics, its an important time for consumers and benefits managers to understand how the transition from brand to generic will affect drug prices going forward.